Precigen
PGEN
#5445
Rank
HK$10.15 B
Marketcap
HK$28.71
Share price
2.50%
Change (1 day)
361.23%
Change (1 year)

Revenue for Precigen (PGEN)

Revenue in 2025 (TTM): HK$33.79 Million

According to Precigen's latest financial reports the company's current revenue (TTM ) is HK$33.76 Million. In 2024 the company made a revenue of HK$30.47 Million a decrease over the revenue in the year 2023 that were of HK$48.61 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Precigen from 2012 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) HK$33.79 M10.92%
2024 HK$30.47 M-37.32%
2023 HK$48.61 M-76.88%
2022 HK$0.21 B-51.75%
2021 HK$0.43 B-45.52%
2020 HK$0.79 B25.13%
2019 HK$0.63 B-49.16%
2018 HK$1.25 B-30.4%
2017 HK$1.80 B22.02%
2016 HK$1.48 B10.03%
2015 HK$1.34 B141.17%
2014 HK$0.55 B206.34%
2013 HK$0.18 B68.74%
2012 HK$0.10 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Novocure
NVCR
HK$4.99 B 14,698.82% Jersey
Novavax
NVAX
HK$7.96 B 23,502.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Organovo
ONVO
HK$1.12 M-96.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Orchard Therapeutics
ORTX
HK$0.16 B 403.20%๐Ÿ‡ฌ๐Ÿ‡ง UK